Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J Sprouts Innovation Centers In Industry Hot Spots

This article was originally published in The Tan Sheet

Executive Summary

In an effort to expand outreach to and interaction with innovation-rich communities, J&J creates four new regional innovation centers to act as scouts, dealmakers and alliance managers in Boston, California, London and Shanghai.

You may also be interested in...



In Brief: Helen Of Troy In Supplements; J&J Innovation; U.K. Ad Enforcement; CHPA Chairman-elect; Hispanic Consumer Health

Helen Of Troy Acquires Supplement Firm; J&J eyes probiotics to skin, oral health and respiratory conditions; ASA rules on Danon Baby Nutrition ad; FDA continues to pursue tainted supplements; FDA warns about tainted bee pollen; CHPA names board chair-elect; and USP educates Hispanics about supplements.

In Brief: Helen Of Troy In Supplements; J&J Innovation; U.K. Ad Enforcement; CHPA Chairman-elect; Hispanic Consumer Health

Helen Of Troy Acquires Supplement Firm; J&J eyes probiotics to skin, oral health and respiratory conditions; ASA rules on Danon Baby Nutrition ad; FDA continues to pursue tainted supplements; FDA warns about tainted bee pollen; CHPA names board chair-elect; and USP educates Hispanics about supplements.

Backing New Index Fund, GSK, J&J Buy Into Asset-Centric Vision Of Biotech Future

Index Life VI is the first life-sciences-only fund for Index; GSK’s Moncef Slaoui and J&J’s Paul Stoffels are on scientific advisory board.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS106002

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel